Tulane Cancer Center

Biographical Narrative:

Dr. Julie Kanter received her medical degree in 2003 from Tulane University School of Medicine in New Orleans, Lousiana.  She went on to complete her pediatric residency at The Children's Hospital at the University of Colorado from 2003-2006.  In 2006, Dr. Kanter then completed her fellowship training in pediatric hematology-oncology at Washington University in S. Louis, Missouri.  During her fellowship, Dr. Kanter participated actively in multiple clinical research projects including the use of Alemtuzumab in reduced intensity bone marrow transplants and the use of Rituximab in chronic idiopathic thrombocytopenic purpura.  She also worked in translational research in platelet storage and transfusion on which she presented the abstract "Platelets in Storage: Altered S-Nitrosothiol Metabolism and Decreased Responsiveness May Be Related," at the American Society of Hematology Conference in 2005.  She joined the Tulane University faculty as an assistant professor of pediatrics in the section of hematology and oncology in 2009.  At Tulane University, Dr. Kanter is pursuing clinical research projects on neuropsychological treatments in adolescent cancer patients, stem cell transplant in sickle cell disease, and sickle cell disease modulation therapy. Dr. Kanter is the primary investigator for pediatric stem cell transplant at Tulane as well as the Director of the Sickle Cell Center of Southern Louisiana. She is also an active member of several medical societies including the Peripheral Blood and Marrow Transplant (PBMTC) Consortium, the Children's Oncology Group, and the American Society of Hematology.

Selected Publications:

"Pharmacokinetics of Alemtuzumab Used as Conditioning Agent in Reduced Intensity Transplantation for Pediatric Non-Malignant Disorders." Kanter J, Kanthamneni M, Witty S, Barnes Y, Hayashi R, and Shenoy S. (in process)

Kanter J, Khan SY, Kelher M, Gore L, and Silliman CC. Oncogenic and angiogenic growth factors accumulate during routine storage of apheresis platelet concentrates. Clin Cancer Res. 2008 Jun 15;14(12):3942-7